Related Experiment Video
Updated: Aug 23, 2026
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers
Rui Rong Yuan1, Phillip Wong, Michael R McDevitt
1Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Abstract:
Immunosuppressive agents in current use are nonspecific. The capacity to delete specific CD8 T-cell clones of unique specificity could prove to be a powerful tool for dissecting the precise role of CD8(+) T cells in human disease and could form the basis for a safe, highly selective therapy of autoimmune disorders. Major histocompatibility complex (MHC) tetramers (multimeric complexes capable of binding to specific CD8 T-cell clones) were conjugated to (225)Ac (an alpha-emitting atomic nanogenerator, capable of single-hit killing from the cell surface) to create an agent for CD8 T-cell clonal deletion. The "suicide" tetramers specifically bound to, killed, and reduced the function of their cognate CD8 T cells (either human anti-Epstein-Barr virus (EBV) or mouse anti-Listeria in 2 model systems) while leaving the nonspecific control CD8 T-cell populations unharmed. Such an approach may allow a pathway to selective ablation of pathogenic T-cell clones ex vivo or in vivo without disturbing general immune function.
Insights
Researchers developed "suicide" tetramers to precisely eliminate specific CD8 T cells. This targeted approach offers a potential new therapy for autoimmune disorders by selectively removing harmful T cells without affecting overall immune function.
Area of Science:
- Immunology
- Radiochemistry
- Molecular Biology
Background:
- Current immunosuppressive agents lack specificity.
- Targeted deletion of specific CD8 T-cell clones is needed for disease research and autoimmune disorder therapy.
Purpose of the Study:
- To create a novel agent for selective CD8 T-cell clonal deletion.
- To investigate the potential of MHC tetramers conjugated to alpha-emitters for targeted cell killing.
Main Methods:
- Conjugation of Major Histocompatibility Complex (MHC) tetramers with Actinium-225 ((225)Ac), an alpha-emitting radioisotope.
- Utilizing these "suicide" tetramers to target and eliminate specific CD8 T-cell clones in human (anti-Epstein-Barr virus) and mouse (anti-Listeria) models.
Main Results:
- The "suicide" tetramers specifically bound to and killed cognate CD8 T cells.
- Functional reduction of targeted CD8 T-cell populations was observed.
- Nonspecific CD8 T-cell populations remained unharmed, demonstrating selectivity.
Conclusions:
- MHC tetramer- (225)Ac conjugates are effective agents for selective CD8 T-cell clonal deletion.
- This approach holds promise for ex vivo or in vivo ablation of pathogenic T-cell clones.
- Potential for developing safe and highly selective therapies for autoimmune disorders.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...